About 773,000 results
Open links in new tab
Enhertu showed substantial clinical activity in patients with HER2 ...
Enhertu demonstrated a median progression-free survival of 13.2 …
Enhertu Effective in HER2-Positive Metastatic Breast Cancer
ENHERTU® Showed Substantial Clinical Activity in Patients with …
Enhertu Approved for Any HER2-Positive Solid Cancer - NCI
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the …
Enhertu Breast Cancer Drug Results in ‘Unheard-of’ Survival …
ENHERTU - Business Wire
Trastuzumab Deruxtecan for Metastatic HER2-Low Breast Cancer
A New Standard of Care? Enhertu Improves Survival in People …